E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/21/2005 in the Prospect News PIPE Daily.

New Issue: Uroplasty wraps $7.7 million private placement of stock

By Sheri Kasprzak

Atlanta, April 21 - Uroplasty Inc. has completed a private placement of stock for $7.7 million.

The company sold 2.2 million shares at $3.50 each to institutional investors.

The investors also received warrants for 1.1 million shares, exercisable at $4.75 each for five years.

Craig Hallum Capital Group LLC was the placement agent.

Based in Minneapolis, Uroplasty develops, manufactures and markets medical devices used to treat urinary ailments. The proceeds will be used for general corporate purposes, including sales, marketing and product development.

Issuer:Uroplasty Inc.
Issue:Stock
Amount:$7.7 million
Shares:2.2 million
Price:$3.50
Warrants:For 1.1 million shares
Warrant expiration:Five years
Warrant strike price:$4.75
Placement agent:Craig Hallum Capital Group LLC
Settlement date:April 21
Stock price:$4.05 at close April 21

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.